Gary Sinclair

3.1k total citations · 1 hit paper
25 papers, 2.3k citations indexed

About

Gary Sinclair is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Gary Sinclair has authored 25 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Gary Sinclair's work include Platelet Disorders and Treatments (4 papers), Blood disorders and treatments (4 papers) and Hemophilia Treatment and Research (4 papers). Gary Sinclair is often cited by papers focused on Platelet Disorders and Treatments (4 papers), Blood disorders and treatments (4 papers) and Hemophilia Treatment and Research (4 papers). Gary Sinclair collaborates with scholars based in Canada, Malaysia and Denmark. Gary Sinclair's co-authors include Christopher J. Doig, Rebekah DeVinney, Kamala D. Patel, Zahra Goodarzi, Francis H. Y. Green, Paul Kubes, Elizabeth Keys, Braedon McDonald, Erin F. McAvoy and Stephen Clark and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Blood.

In The Last Decade

Gary Sinclair

25 papers receiving 2.3k citations

Hit Papers

Platelet TLR4 activates neutrophil extracellular traps to... 2007 2026 2013 2019 2007 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Sinclair Canada 13 1.4k 740 578 332 307 25 2.3k
M. R. Daha Netherlands 27 1.3k 0.9× 464 0.6× 320 0.6× 398 1.2× 334 1.1× 68 2.5k
Erin F. McAvoy Canada 6 1.5k 1.1× 407 0.6× 499 0.9× 290 0.9× 348 1.1× 9 2.1k
M Fotino United States 28 1.1k 0.8× 328 0.4× 356 0.6× 247 0.7× 307 1.0× 78 2.5k
Walter H.A. Kahr Canada 30 659 0.5× 1.3k 1.7× 474 0.8× 370 1.1× 192 0.6× 94 2.5k
Makoto Hirokawa Japan 28 983 0.7× 576 0.8× 363 0.6× 292 0.9× 181 0.6× 121 2.6k
Jiří Litzman Czechia 31 2.1k 1.5× 390 0.5× 274 0.5× 358 1.1× 349 1.1× 105 2.8k
Davit Manukyan Germany 10 723 0.5× 470 0.6× 360 0.6× 242 0.7× 214 0.7× 17 1.6k
Barry L. Myones United States 21 917 0.7× 445 0.6× 268 0.5× 142 0.4× 264 0.9× 43 2.0k
R. A. Thompson United Kingdom 23 1.0k 0.7× 471 0.6× 276 0.5× 175 0.5× 372 1.2× 67 2.0k
Andrew R. Crow Canada 23 925 0.7× 1.1k 1.6× 251 0.4× 107 0.3× 155 0.5× 40 2.0k

Countries citing papers authored by Gary Sinclair

Since Specialization
Citations

This map shows the geographic impact of Gary Sinclair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Sinclair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Sinclair more than expected).

Fields of papers citing papers by Gary Sinclair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Sinclair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Sinclair. The network helps show where Gary Sinclair may publish in the future.

Co-authorship network of co-authors of Gary Sinclair

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Sinclair. A scholar is included among the top collaborators of Gary Sinclair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Sinclair. Gary Sinclair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berhe, Mezgebe, et al.. (2024). Activité antivirale, tolérance et pharmacocinétique du GS-1720, un nouvel INI oral hebdomadaire. 3(2). S139–S139. 1 indexed citations
2.
Mahé, Etienne, Kasper Mønsted Pedersen, Yunus Çolak, et al.. (2018). JAK2-tree: a simple CBC-based decision rule to guide appropriate JAK2 V617F mutation testing. Journal of Clinical Pathology. 72(2). 172–176. 10 indexed citations
3.
Mughal, Muhammad Kashif, Ghaleb Elyamany, Gary Sinclair, et al.. (2016). Multiplexed automated digital quantification of fusion transcripts: comparative study with fluorescent in-situ hybridization (FISH) technique in acute leukemia patients. Diagnostic Pathology. 11(1). 89–89. 6 indexed citations
6.
Khan, Faisal, Judy Chernos, Noureddine Berka, et al.. (2010). Nasal Epithelial Cells of Donor Origin after Allogeneic Hematopoietic Cell Transplantation are Generated at a Faster Rate in the First 3 Months Compared with Later Posttransplantation. Biology of Blood and Marrow Transplantation. 16(12). 1658–1664. 7 indexed citations
7.
Owen, Carolyn, Cynthia L. Toze, Donna L. Forrest, et al.. (2008). Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. Blood. 112(12). 4639–4645. 168 indexed citations
8.
Jackson, Shannon, et al.. (2008). The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation. Blood. 113(14). 3348–3351. 30 indexed citations
9.
Clark, Stephen, Samantha A. Tavener, Braedon McDonald, et al.. (2007). Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nature Medicine. 13(4). 463–469. 1778 indexed citations breakdown →
10.
James, Paula, Lee A. O’Brien, Carol Hegadorn, et al.. (2004). A novel type 2A von Willebrand factor mutation located at the last nucleotide of exon 26 (3538G>A) causes skipping of 2 nonadjacent exons. Blood. 104(9). 2739–2745. 12 indexed citations
11.
Sinclair, Gary, et al.. (1997). A Hemi-nested, Allele Specific, Whole Blood PCR Assay for the Detection of the Factor V Leiden Mutation. Thrombosis and Haemostasis. 77(6). 1154–1155. 6 indexed citations
12.
Berthiaume, Yves, Paul Boiteau, Gordon H. Fick, et al.. (1995). Pulmonary Edema During IL-2 Therapy: Combined Effect of Increased Permeability and Hydrostatic Pressure. American Journal of Respiratory and Critical Care Medicine. 152(1). 329–335. 12 indexed citations
13.
Poon, Man‐Chiu, et al.. (1995). Factor VIII gene rearrangement analysis and carrier determination in hemophilia A.. PubMed. 125(3). 402–6. 4 indexed citations
14.
Poon, Man‐Chiu, et al.. (1992). Hemophilia A carrier detection by restriction fragment length polymorphism analysis and discriminant analysis based on ELISA of factor VIII and vWf.. PubMed. 119(6). 751–62. 5 indexed citations
15.
Poon, Man‐Chiu, J A Russell, Gary Sinclair, et al.. (1989). Hemopoietic origin of factor XIII A subunits in platelets, monocytes, and plasma. Evidence from bone marrow transplantation studies.. Journal of Clinical Investigation. 84(3). 787–792. 46 indexed citations
16.
Sinclair, Gary, Arturo Ortíz Wadgymar, Philip F. Halloran, & T L Delovitch. (1984). Graft-vs-host reactions induce H-2 class II gene transcription in host kidney cells. Immunogenetics. 20(5). 503–511. 27 indexed citations
18.
Sinclair, Gary & Gordon H. Dixon. (1982). Purification and characterization of cytoplasmic protamine messenger ribonucleoprotein particles from rainbow trout testis cells. Biochemistry. 21(8). 1869–1877. 36 indexed citations
19.
Sinclair, Gary, et al.. (1979). Speed of response characteristics of goalkeepers: a descriptive and developmental report.. PubMed. 4(1). 60–5. 2 indexed citations
20.
Sinclair, Gary & Klaus Brasch. (1975). The nucleated erythrocyte: a model of cell differentiation.. PubMed. 34(4). 287–303. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026